ʯÁñÊÓÆµ»ÆÉ«°æ

ʯÁñÊÓÆµ»ÆÉ«°æ

MUSC and Simens Healthineers

Joint Development Grant

MUSC-Siemens Photon Counting Computed Tomography Pilot Project Grant

KEY DATES

RFA Released: January 13, 2022
Applications Due: 5 PM EST, March 22, 2022
Anticipated Project Start Date: April 26, 2022

OVERVIEW

This RFA solicits grant applications proposing novel, advanced, or enhanced uses of Siemens Photon Counting Computed Tomography (PCCT) technology. Co-sponsored by the MUSC Office of Innovation, Siemens Healthineers, and South Carolina Clinical and Translational Research (SCTR) Institute, this RFA provides one grant of up to $50,000 for a 12-month period in funding and access to Siemens technology, supporting a PCCT-related pilot project designed to yield preliminary findings to expand clinical utility of a technology, support subsequent extramural grant applications, and/or result in joint product or service development. The aims specified by the application must be distinguishable from those funded by other grants. Proposals may involve novel PCCT protocol optimization and/or clinical application.

Specific priority areas include*:

  • Pulmonary/Lung
  • Neurology/Brain
  • Cancer/Oncology

*No applications outside of these priority areas will be considered.
Ìý

APPLICATION REVIEW

Applications will be reviewed by a panel including scientific/technical evaluators, members from an external review board comprising MUSC and Siemens representatives, and Office of Innovation leadership.

Applications will be assessed to determine the potential for a project to:

  • Expand the clinical utility of Siemens PCCT technology and improve patient care.
  • Produce data that can be the basis for a larger-scale study with a subsequent extramural grant application, e.g., National Institutes of Health.
  • Result in new, jointly developed innovations.

Additionally, work proposed in the application will be reviewed for:

  • Likely completion of the aims within one-year time-frame
  • Appropriateness of the proposed budget expenditures with respect to the development plan for the innovation
  • Measurable, meaningful milestones for quarterly reporting

Official RFA

APPLICATION SUBMISSION

All applications must be submitted through InfoReady, an online application and review system by following this .

FOR ADDITIONAL INFORMATION

Preliminary proposal discussion and questions about PCCT technology at MUSC
Jim O’Doherty, Ph.D. (odoherty@musc.edu or or james.odoherty@siemens-healthineers.com)

PCCT charge estimates for proposal budgeting
Office of Clinical Research (musc-ocr@musc.edu))

InfoReady and proposal submission process
Dayan Ranwala, Ph.D. (ranwala@musc.edu)